Clinical Trial Update: Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft [NA]

View source ↗

Summary

A completed clinical trial comparing AlloStem bone graft substitute to autologous bone graft for subtalar arthrodesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Osteoarthritis
• Inflammatory Polyarthritis
• Post-traumatic Osteoarthritis
• Rheumatoid Arthritis
• Rheumatoid Arthritis of Subtalar Joint

Drugs mentioned

• AlloStem
• Autologous bone graft (autologous bone graft)

Snippet

Sponsor: AlloSource | Conditions: Degenerative Osteoarthritis, Post-traumatic; Arthrosis | NA | Status: COMPLETED